Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-24

Clinical Trial Update: Desflurane-induced Myocardial Protection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating whether desflurane provides myocardial protection in patients with aortic valve stenosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DESFLURANE (DESFLURANE)

Snippet

Sponsor: Nobuyuki Katori | Conditions: Aortic Valve Stenosis | Phase 4 | Status: UNKNOWN